Pharmavene, Shire Pharmaceuticals Group PLC deal

SHP plans to acquire Pharmavene for £55.5 million ($90.5 million) in cash and stock, including $25 million in cash and $65.5

Read the full 210 word article

How to gain access

Continue reading with a
two-week free trial.